Topics
trigeminal nerveAnatomical structure
botulinum toxinChemical substance
trigeminal neuralgiaDisease
Trigeminal neuralgiaDisease
Copyright © 2013 Gaurav Verma.This is an open access article distributed under theCreativeCommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Trigeminal neuralgia (TN) is a clinical condition characterized by paroxysmal attacks of severe and electric shock-like pain along the distribution of one or more branches of the trigeminal nerve. Various medicinal or surgical modalities have been employed in the past with variable success. Newer methods were tried in search of permanent cure or long-lasting pain relief. The purpose of this paper is to present the review of the literature regarding the use of botulinum toxin type-A (BTX-A) in the manage...
Pain and fear of pain continue to be the commonest and strongest motivation for the people to seek f...
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-...
Mark Obermann Department of Neurology, University of Duisburg-Essen, Essen, Germany Abstract: Despi...
Trigeminal neuralgia is a chronic pain condition associated with sharp, shock-like pain in one or mo...
Introduction. Trigeminal neuralgia (TN) is one of the most common neurological diseases involving th...
The effects of botulinum toxin have been demonstrated in pain syndromes such as migraine, tension he...
Trigeminal neuralgia (TN) is a disorder characterized by severe abrupt lancinating pains, limited to...
The purpose of this article is to systematically review the use, efficacy, differences between Botul...
Background: Trigeminal neuralgia is a chronic disease characterised by recurrent attacks of brief ep...
ChinaTrigeminal neuralgia (TN) is characterized by sudden (usually unilateral), severe, brief, stabb...
This article illustrates a case of persistent trigeminal neuralgia in a medically compromised 65-yea...
Objective. To assess the therapeutic efficacy and safety of botulinum toxin type A (BTX-A) for treat...
Botulinum toxins (BoNTs) are a product of the bacteria Clostridium botulinum. By entering nerve endi...
Botulinum toxin type A for trigeminal neuralgia – we have the prima facie evidence Response: We than...
Copyright © 2012 Yoshizo Matsuka et al. This is an open access article distributed under the Creativ...
Pain and fear of pain continue to be the commonest and strongest motivation for the people to seek f...
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-...
Mark Obermann Department of Neurology, University of Duisburg-Essen, Essen, Germany Abstract: Despi...
Trigeminal neuralgia is a chronic pain condition associated with sharp, shock-like pain in one or mo...
Introduction. Trigeminal neuralgia (TN) is one of the most common neurological diseases involving th...
The effects of botulinum toxin have been demonstrated in pain syndromes such as migraine, tension he...
Trigeminal neuralgia (TN) is a disorder characterized by severe abrupt lancinating pains, limited to...
The purpose of this article is to systematically review the use, efficacy, differences between Botul...
Background: Trigeminal neuralgia is a chronic disease characterised by recurrent attacks of brief ep...
ChinaTrigeminal neuralgia (TN) is characterized by sudden (usually unilateral), severe, brief, stabb...
This article illustrates a case of persistent trigeminal neuralgia in a medically compromised 65-yea...
Objective. To assess the therapeutic efficacy and safety of botulinum toxin type A (BTX-A) for treat...
Botulinum toxins (BoNTs) are a product of the bacteria Clostridium botulinum. By entering nerve endi...
Botulinum toxin type A for trigeminal neuralgia – we have the prima facie evidence Response: We than...
Copyright © 2012 Yoshizo Matsuka et al. This is an open access article distributed under the Creativ...
Pain and fear of pain continue to be the commonest and strongest motivation for the people to seek f...
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-...
Mark Obermann Department of Neurology, University of Duisburg-Essen, Essen, Germany Abstract: Despi...
Add to ORKG